Cargando…

M35. CLINICAL VALIDATION OF THE SIX-ITEM POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS-6)

BACKGROUND: The development of the brief and psychometrically valid, six-item Positive and Negative Syndrome Scale (PANSS-6) holds promise to improve the treatment of schizophrenia by paving the way for implementation of measurement-based care. However, an important limitation to the existing studie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kølbæk, Pernille, Dines, David, Holm, Tine, Blicher, Anne B, Sørensen, Rune D, O’Leary, Kathrine M, Feller, Sandra G, Buus, Chanette W, Nielsen, Cecilie M, Opler, Mark, Mors, Ole, Correll, Christoph U, Østergaard, Søren D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Session II
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234248/ http://dx.doi.org/10.1093/schbul/sbaa030.347

Ejemplares similares

Standardized training in the rating of the six-item positive and negative syndrome scale (PANSS-6)
por: Kølbæk, P., et al.
Publicado: (2021)

Are informants required to obtain valid ratings on the Positive and Negative Syndrome Scale (PANSS)?
por: Nielsen, Cecilie Marie, et al.
Publicado: (2023)

S244. RELIABILITY OF CORE SCHIZOPHRENIA SYMPTOMS RATINGS USING THE SIX-ITEM POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS-6) PERFORMED BY MEDICAL STUDENTS
por: Hansen, Johanna, et al.
Publicado: (2020)

Antipsychotic-placebo separation on the PANSS-6 subscale as compared to the PANSS-30: a pooled participant-level analysis
por: Hieronymus, Fredrik, et al.
Publicado: (2021)

S48. INTER-RATER RELIABILITY OF PANSS-6 SCHIZOPHRENIA SEVERITY RATINGS OBTAINED USING THE SIMPLIFIED NEGATIVE AND POSITIVE SYMPTOMS INTERVIEW (SNAPSI)
por: Kølbæk, Pernille, et al.
Publicado: (2018)

M42. INDEPENDENT REVIEW & MONITORING IMPROVES QUALITY OF PANSS DATA IN GLOBAL CLINICAL TRIALS
por: Echevarria, Barbara, et al.
Publicado: (2020)

S46. THE VALIDITY AND SENSITIVITY OF PANSS-6 IN TREATMENT-RESISTANT SCHIZOPHRENIA
por: Ostergaard, Soren Dinesen, et al.
Publicado: (2018)

M210. GRIN2B METHYLATION IS RELATED TO PANSS EXCITED COMPONENT (PANSS-EC) IN SCHIZOPHRENIA
por: Fachim, Helene, et al.
Publicado: (2020)

M40. ECT VERSUS SHAM FOR CLOZAPINE RESISTANT SCHIZOPHRENIA: A SECONDARY ANALYSIS OF A PILOT STUDY BASED ON PANSS-30 FACTOR ANALYTIC DIMENSIONS AND THE PANSS-6
por: Luciana Melzer-Ribeiro, Debora, et al.
Publicado: (2020)

Initial severity of the Positive and Negative Syndrome Scale (PANSS)-30, its main subscales plus the PANSS-6, and the relationship to subsequent improvement and trial dropout: a pooled participant-level analysis of 18 placebo-controlled risperidone and paliperidone trials
por: Hieronymus, Fredrik, et al.
Publicado: (2023)

Clinical validation of the self-rated 6-item Hamilton Depression Rating Scale among inpatients
por: Kølbæk, P., et al.
Publicado: (2022)

Item Response Theory to Quantify Longitudinal Placebo and Paliperidone Effects on PANSS Scores in Schizophrenia
por: Krekels, EHJ, et al.
Publicado: (2017)

S37. CROSS-CULTURAL DIFFERENCES IN PANSS ITEM RATINGS: COMPARISONS OF SIX GEO-CULTURAL REGIONS
por: Crittenden, Kia, et al.
Publicado: (2020)

Depressive Symptoms and PANSS Symptom Dimensions in Patients With Predominant Negative Symptom Schizophrenia: A Network Analysis
por: Demyttenaere, Koen, et al.
Publicado: (2022)

A rasch model to test the cross-cultural validity in the positive and negative syndrome scale (PANSS) across six geo-cultural groups
por: Khan, Anzalee, et al.
Publicado: (2013)

Use of NON-PARAMETRIC Item Response Theory to develop a shortened version of the Positive and Negative Syndrome Scale (PANSS)
por: Khan, Anzalee, et al.
Publicado: (2011)

Is the PANSS used correctly? a systematic review
por: Obermeier, Michael, et al.
Publicado: (2011)

F119. MULTILEVEL ANALYSIS IMPROVES THE MODEL FIT OF THE DIMENSIONAL STRUCTURE OF THE PANSS IN PATIENTS WITH SCHIZOPHRENIA
por: Higuchi, Cinthia, et al.
Publicado: (2018)

Patterns of schizophrenia symptoms: hidden structure in the PANSS questionnaire
por: Lefort-Besnard, Jérémy, et al.
Publicado: (2018)

T56. AN EXPLORATORY ANALYSIS CONVERTING SCORES BETWEEN THE PANSS AND BNSS
por: Kott, Alan, et al.
Publicado: (2018)

Staging of Schizophrenia With the Use of PANSS: An International Multi-Center Study
por: Fountoulakis, Konstantinos N, et al.
Publicado: (2019)

M205. LONG-TERM SAFETY OF LUMATEPERONE (ITI-007): METABOLIC EFFECTS IN A 1-YEAR STUDY
por: Satlin, Andrew, et al.
Publicado: (2020)

Factor analysis of the relationship between PANSS score and family burden of patients with schizophrenia
por: Huang, Jiang, et al.
Publicado: (2021)

The Correlation of Positive and Negative Symptoms (PANSS Scores) in Patients with Schizophrenia According to Gender
por: Sulejmanpasic, Gorana, et al.
Publicado: (2023)

Self-reported mental health among individuals with mental disorders during the COVID-19 pandemic
por: Østergaard, S., et al.
Publicado: (2021)

Consensus five factor PANSS for evaluation of clinical remission: effects on functioning and cognitive performances
por: Pinna, Federica, et al.
Publicado: (2014)

M41. TRAJECTORIES AND PREDICTORS OF OUTCOME IN SCHIZOPHRENIA: THE BENEFICIAL ROLE OF AMISULPRIDE
por: Drosos, Petros, et al.
Publicado: (2020)

Response to inhaled loxapine in patients with schizophrenia or bipolar I disorder: PANSS-EC responder analyses
por: Zeller, Scott, et al.
Publicado: (2017)

S71. CLINICAL, BEHAVIOURAL AND NEURAL VALIDATION OF THE POSITIVE AND NEGATIVE SYMPTOM SCALE (PANSS) AMOTIVATION FACTOR
por: Kaliuzhna, Mariia, et al.
Publicado: (2020)

M57. NEUROCOGNITIVE HETEROGENEITY IN 7-YEAR-OLD CHILDREN AT FAMILIAL HIGH RISK OF SCHIZOPHRENIA OR BIPOLAR DISORDER - THE DANISH HIGH RISK AND RESILIENCE STUDY VIA 7
por: Hemager, Nicoline, et al.
Publicado: (2020)

The impact of the COVID-19 pandemic on individuals with mental illness: A two-wave survey of 1180 patients
por: Gil, Y., et al.
Publicado: (2021)

M56. ASSORTATIVE MATING IN SCHIZOPHRENIA AND BIPOLAR DISORDER: A NATIONWIDE COHORT STUDY EXPLORING THE CHARACTERISTICS OF INDIVIDUALS WHO HAVE CHILDREN BY PARTNERS WITH SCHIZOPHRENIA OR BIPOLAR DISORDER
por: Greve, Aja, et al.
Publicado: (2020)

Items analysis of the Frailty Index (FI-35): Insight in the contribution of each item to the level of frailty
por: Zhang, Xiaohong, et al.
Publicado: (2021)

M47. AKATHISIA AND ATYPICAL ANTIPSYCHOTICS: EXPLORING ASSOCIATIONS TO SUICIDALITY AND AGITATION
por: Bjarke, Jill, et al.
Publicado: (2020)

Utility of Two PANSS 5-Factor Models for Assessing Psychosocial Outcomes in Clinical Programs for Persons with Schizophrenia
por: Jerrell, Jeanette M., et al.
Publicado: (2013)

T111. PANSS NEGATIVE SYMPTOM DIMENSIONS ACROSS GEOGRAPHICAL REGIONS: IMPLICATIONS FOR SOCIAL, LINGUISTIC AND CULTURAL CONSISTENCY
por: Khan, Anzalee, et al.
Publicado: (2018)

The Comparison of Olanzapine and Risperidone Treatment in Male Schizophrenic Patients using Positive and Negative Syndromes Scale (PANSS)
por: Lestari, Endah Tri, et al.
Publicado: (2018)

Application of machine learning to predict reduction in total PANSS score and enrich enrollment in schizophrenia clinical trials
por: Podichetty, Jagdeep T., et al.
Publicado: (2021)

Changes in neurotransmitter levels, brain structural characteristics, and their correlation with PANSS scores in patients with first-episode schizophrenia
por: Xu, Xian-Jia, et al.
Publicado: (2023)

M146. NEUROCHEMICAL MODULATION OF AUDITORY CORTEX FUNCTIONAL CONNECTIVITY IN PATIENTS WITH AUDITORY VERBAL HALLUCINATIONS
por: Weber, Sarah, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q88cjc3sqv9go8q8mhto0mlqo6